| Invasive ventilation (28-day) | Mortality (28-day) | ||
---|---|---|---|---|
Threshold | MIMIC-IV | AmsterdamUMCdb | MIMIC-IV | AmsterdamUMCdb |
Oxygenation thresholds | ||||
SF < 110 | 71.8 (70.4 to 73.0) | 50.9 (44.9 to 55.3) | 22.2 (19.5 to 25.0) | 14.6 (7.7 to 22.3) |
SF < 98 | 47.0 (45.6 to 48.5) | 27.7 (19.1 to 34.2) | 24.1 (22.0 to 26.9) | 13.2 (6.3 to 20.8) |
SF < 88 | 19.4 (18.0 to 20.9) | 19.0 (9.2 to 26.2) | 25.8 (23.5 to 28.3) | 12.7 (6.0 to 20.4) |
Usual care | ||||
Observed | 26.7 (25.2 to 28.2) | 36.8 (34.1 to 39.5) | 22.2 (20.8 to 23.6) | 17.4 (15.3 to 19.6) |
Modeled | 31.5 (29.7 to 33.5) | 45.7 (38.4 to 50.7) | 25.1 (22.9 to 27.8) | 14.1 (6.7 to 22.3) |
Secondary outcomes: respiratory rate | ||||
SF < 98 and RR > 25 | 32.9 (31.4 to 34.4) | 24.6 (15.4 to 31.4) | 25.0 (22.9 to 27.7) | 13.0 (6.3 to 20.7) |
SF < 98 and RR > 35 | 16.3 (15.0 to 17.6) | 21.0 (11.3 to 27.9) | 25.9 (23.7 to 28.5) | 12.8 (6.1 to 20.8) |
Secondary outcomes: work of breathing | ||||
SF < 98 and abnormal work of breathing | 33.5 (31.9 to 35.2) | – | 24.9 (22.8 to 27.7) | – |
Secondary outcomes: duration | ||||
SF < 98 for 2 consecutive hours | 27.6 (26.0 to 29.0) | 19.9 (10.2 to 26.9) | 25.3 (23.2 to 28.1) | 12.7 (5.9 to 20.7) |
SF < 98 for 4 consecutive hours | 19.8 (18.4 to 21.2) | 18.1 (8.1 to 25.3) | 25.8 (23.6 to 28.3) | 12.6 (5.9 to 20.4) |
Secondary outcomes: trajectory | ||||
SF predicted to be less than 88 in 30Â min | 67.5 (66.2 to 68.8) | 51.0 (44.8 to 55.3) | 22.6 (20.1 to 25.4) | 14.4 (6.7 to 22.9) |
SF predicted to be less than 88 in 60Â min | 43.0 (41.5 to 44.4) | 26.2 (17.1 to 32.9) | 24.4 (22.3 to 27.2) | 13.0 (6.1 to 21.0) |
Secondary outcomes: randomized trial criteria | ||||
Respiratory, hemodynamic, or neurologic trial criteria | 65.5 (64.2 to 66.8) | 64.7 (59.8 to 68.3) | 22.5 (19.9 to 25.4) | 15.7 (9.0 to 22.3) |
Respiratory and hemodynamic or neurologic trial criteria | 16.1 (14.8 to 17.5) | 19.2 (9.2 to 26.5) | 25.9 (23.7 to 28.6) | 12.7 (6.1 to 20.4) |